Comprehensive Centers Balk At “Requiring” All Control Programs To Be Funneled Through Them
In Brief: NCI Study Finds No Relation Of Fluoridated Water To Cancer Incidence In U.S. Counties
FDA Told To Drop Guidelines, But Remains Unmoved On New Drug Delays
Shubik Subcommittee Criticizes New Study Section, Asks NCI To Hire More Epidemiologists
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?









